Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study
The Oncologist · 2024
DOI: 10.1093/oncolo/oyae111 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift The Oncologist, 2024. Verfasst von Jan Räder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg, 79106 Freiburg, Germany. Hauptthemen laut MEDLINE: Multiple Myeloma, Exercise, Motivation, Quality of Life. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Multiple myeloma (MM) is the second most common hematological malignancy with its prevalence increasing. Patients with symptomatic MM can show numerous comorbidities, affecting their quality of life (QoL). Physical activity (PA) may improve QoL but is not a standardized intervention of comprehensive cancer centers (CCCs). Since data on the PA of patients with MM are scarce, we aimed to prospectively assess fitness levels and patients’ motivation to join PA-interventions at our CCC.
Methods
We generated an exercise questionnaire to interview consecutive patients MM. We prospectively collected data on (a) past and current PA, defined by the World Health Organization (WHO) recommendations, (b) knowledge on exercise effects, (c) exercise motivation, and (d) willingness to participate in PA-interventions. Demographics, comorbidities, response, progression-free survival (PFS), and overall survival (OS) were assessed in 211 symptomatic patients MM.
Results
While our patients were elderly and most showed bone involvement, their PA was similar to healthy individuals. Aerobic PA (≥ 60 minutes/week) was performed by 65%, and 25% exercised ≥ 150 minutes/week. WHO PA recommendations were fulfilled by 17% of patients. No sport activities or complete physical inactivity were observed in 35% and 16%, respectively. Notably, 38% were motivated to join MM-specific sport interventions. Self-reported knowledge of PA-induced benefits for patients cancer was high (82%), but only 27% knew which exercises were safe to perform.
Conclusion
This study provides an overview of the PA of patients MM. Our results suggest that the PA of patients MM might not be much lower than in the age-matched general population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg, 79106 Freiburg, Germany.
- Comprehensive Cancer Center Freiburg, Faculty of Medicine and Medical Center, University of Freiburg, 79106 Freiburg, Germany.
- Clinical Trials Unit, Biometry and Statistics, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
- Department of Medicine, Medical Center University of Freiburg, Faculty of Medicine, Institute for Exercise and Occupational Medicine, University of Freiburg, 79106 Freiburg, Germany.
ORCID-Profile: Monika Engelhardt
Zitieren
APA
Räder, J., Ihorst, G., Möller, M. D., Pahl, A., Greil, C., Dreyling, E., Arends, J., Deibert, P., Wäsch, R., & Engelhardt, M. (2024). Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study. The Oncologist. https://doi.org/10.1093/oncolo/oyae111
Vancouver
Räder J, Ihorst G, Möller MD, Pahl A, Greil C, Dreyling E, et al. Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study. The Oncologist. 2024. doi:10.1093/oncolo/oyae111
BibTeX
@article{Rder2024,
author = {Räder, Jan and Ihorst, Gabriele and Möller, Mandy-Deborah and Pahl, Antonia and Greil, Christine and Dreyling, Esther and Arends, Jann and Deibert, Peter and Wäsch, Ralph and Engelhardt, Monika},
title = {Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study},
journal = {The Oncologist},
year = {2024},
doi = {10.1093/oncolo/oyae111}
}
EUVIMED